This is one of the top international meeting points for the pharmaceutical sector specializing in ingredients, outsourcing, equipment and technology, and packaging.
The first partnership is the Vall d’Hebron Research Institute with Pierre Fabre, which have patented a new therapy to promote vasculogenesis after an acute myocardial infarction.
It will be held 25 to 27 September in Montpellier, coinciding with EIC 2013. Biocat is one of the 32 bodies and companies participating in this European project.
One hundred private investors from the IESE network will hear the projects on 27 June under the framework of the MIHealth international clinical innovation congress at the Fira de Barcelona.
With a program of more than 70 activities, it aims to address all of society’s challenges through design in key areas like health, housing, consumption and eco-design.
